Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 93

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 93
---

the securities laws of the United States or any state in the United States, or (ii) entertain original actions brought in Hong Kong against
us or our directors or officers predicated upon the securities laws of the United States or any state in the United States. A judgment
of a court in the United States predicated upon U.S. federal or state securities laws may been forced in Hong Kong at common law by bringing
an action in a Hong Kong court on that judgment for the amount due thereunder, and then seeking summary judgment on the strength of the
foreign judgment, provided that the foreign judgment, among other things, is (1) for a debt or a definite sum of money (not being taxes
or similar charges to a foreign government taxing authority or a fine or other penalty), and (2) final and conclusive on the merits of
the claim, but not otherwise. Such a judgment may not, in any event, be so enforced in Hong Kong if (a) it was obtained by fraud, (b)
the proceedings in which the judgment was obtained were opposed to natural justice, (c) its enforcement or recognition would be contrary
to the public policy of Hong Kong, (d) the court of the United States was not jurisdictionally competent, or (e) the judgment was in
conflict with a prior Hong Kong judgment. Hong Kong has no arrangement for the reciprocal enforcement of judgments with the United States.
As a result, there is uncertainty as to the enforceability in Hong Kong, in original actions or in actions for enforcement, of judgments
of United States courts of civil liabilities predicated solely upon the federal securities laws of the United States or the securities
laws of any State or territory within the United States.

<div align='center'>48

USE OF PROCEEDS</div>

Living Homeopathy estimates that it will receive
net proceeds of $4.07 million from this offering, after deducting the estimated underwriting discounts and the estimated offering expenses
payable by Living Homeopathy and based upon an assumed initial public offering price of $5.00 per Class A Ordinary Share, which is the
midpoint of the price range as set forth on the cover page of this prospectus.

Living Homeopathy plans to use the net proceeds we receive from this offering for the following purposes:

| ● | approximately                                                                                        
 40%, or $1.63 million, for advertising planning, including without limitation, engaging advertising  
 service providers to design advertisement content and place advertisements, and paying advertisement 
 placement